Estrogen Receptor (ER) PET/CT Imaging in Breast Cancer
Recruiting
Observational Study
Breast Cancer
TNBC - Triple-Negative Breast Cancer
Estrogen-receptor-negative Breast Cancer
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 80 (estimated)
- Sponsor
- Tongji Hospital · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
18F-Fluoroestradiol (18F-FES) is an estrogen receptor-targeting positron emission tomography tracer with high sensitivity and specificity for the detection of estrogen receptor（ER）-positive tumors . 18F-FES has been used as a predictive biomarker to demonstrate estrogen receptor heterogeneity , to evaluate the pharmacokinetics of estrogen receptor-targeted drugs ， to measure residual estrogen rece…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* More than 18 years old
* Patients with pathologically confirmed breast cancer
* Sign the informed consent form
Exclusion Criteria:
* Pregnant women
* Severe underlying diseases that cannot cooperate with PET examination
Contacts